← Back to headlines
Barclays Takes Neutral Stance on Gilead Sciences
Barclays has adopted a neutral stance on Gilead Sciences, acknowledging its strategic refocus but maintaining a cautious outlook.
23 Feb, 02:23 — 23 Feb, 02:23
Sources
Showing 1 of 1 sources
